Significant Transaction - Statements of Cash Flows (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | | | |
Jun. 30, 2018 | Jun. 30, 2017 | Jun. 30, 2018 | Jun. 30, 2017 | Jun. 30, 2018 | Dec. 31, 2017 | Jun. 30, 2017 |
Cash flows from operating activities | | | | | | | |
Net income | $ 12 | $ 47 | $ 142 | $ 74 | | | |
Reconciling adjustments: | | | | | | | |
Provision for finance receivable losses | 259 | 233 | 512 | 476 | | | |
Depreciation and amortization | | | 125 | 172 | | | |
Deferred income tax benefit | | | 10 | (19) | | | |
Net loss on repurchases and repayments of debt | 7 | 27 | 8 | 28 | | | |
Share-based compensation expense, net of forfeitures | | | 2 | 3 | | | |
Other | | | 8 | 0 | | | |
Cash flows due to changes in: | | | | | | | |
Other assets and other liabilities | | | | 158 | | | |
Insurance claims and policyholder liabilities | | | | (31) | | | |
Taxes receivable and payable | | | | (31) | | | |
Accrued interest and finance charges | | | | (7) | | | |
Other, net | | | | (2) | | | |
Net cash provided by operating activities | | | 849 | 821 | | | |
Cash flows from investing activities | | | | | | | |
Net principal originations of finance receivables held for investment and held for sale | | | (1,116) | (875) | | | |
Cash advances on intercompany notes receivables | | | (29) | (206) | | | |
Proceeds from repayments of principal on intercompany notes receivables | | | 101 | 110 | | | |
Available-for-sale securities purchased | | | (394) | (351) | | | |
Available-for-sale securities called, sold, and matured | | | 280 | 382 | | | |
Trading and other securities called, sold, and matured | | | 20 | 6 | | | |
Other, net | | | (24) | 4 | | | |
Net cash provided by (used for) investing activities | | | (1,162) | (930) | | | |
Cash flows from financing activities | | | | | | | |
Proceeds from issuance of long-term debt, net of commissions | | | 3,739 | 2,633 | | | |
Repayments of long-term debt | | | (3,776) | (2,254) | | | |
Cash dividend of SFMC | | | 0 | (10) | | | |
Withholding tax on share-based compensation | | | (1) | (2) | | | |
Proceeds from intercompany note payable | | | | 0 | | | |
Payments on intercompany note payable | | | | 0 | | | |
Net cash provided by (used for) financing activities | | | (38) | 367 | | | |
Net change in cash and cash equivalents and restricted cash and restricted cash equivalents | | | (351) | 258 | | | |
Cash and cash equivalents and restricted cash and restricted cash equivalents at beginning of period | | | 1,457 | 1,121 | | | |
Cash and cash equivalents and restricted cash and restricted cash equivalents at end of period | 1,106 | 1,379 | 1,106 | 1,379 | | | |
Supplemental cash flow information | | | | | | | |
Cash and cash equivalents | | | | | $ 520 | $ 958 | $ 834 |
Restricted cash and restricted cash equivalents | | | | | 586 | 498 | 545 |
Total cash and cash equivalents and restricted cash and restricted cash equivalents | $ 1,106 | 1,379 | 1,457 | 1,121 | $ 1,106 | 1,457 | 1,379 |
Supplemental non-cash activities | | | | | | | |
Transfer of finance receivables to real estate owned | | | 3 | 5 | | | |
Net unsettled investment security purchases | | | (1) | (3) | | | |
Non-cash dividend of SFMC | | | $ 0 | (28) | | | |
As Reported SFC | | | | | | | |
Cash flows from operating activities | | | | | | | |
Net income | | 8 | | 35 | | | |
Reconciling adjustments: | | | | | | | |
Provision for finance receivable losses | | 91 | | 162 | | | |
Depreciation and amortization | | | | 75 | | | |
Deferred income tax benefit | | | | (58) | | | |
Net loss on repurchases and repayments of debt | | 27 | | 27 | | | |
Share-based compensation expense, net of forfeitures | | | | 0 | | | |
Other | | | | 2 | | | |
Cash flows due to changes in: | | | | | | | |
Other assets and other liabilities | | | | 111 | | | |
Insurance claims and policyholder liabilities | | | | 5 | | | |
Taxes receivable and payable | | | | 25 | | | |
Accrued interest and finance charges | | | | (29) | | | |
Other, net | | | | (3) | | | |
Net cash provided by operating activities | | | | 352 | | | |
Cash flows from investing activities | | | | | | | |
Net principal originations of finance receivables held for investment and held for sale | | | | (307) | | | |
Cash advances on intercompany notes receivables | | | | (1,335) | | | |
Proceeds from repayments of principal on intercompany notes receivables | | | | 491 | | | |
Available-for-sale securities purchased | | | | (182) | | | |
Available-for-sale securities called, sold, and matured | | | | 136 | | | |
Trading and other securities called, sold, and matured | | | | 1 | | | |
Other, net | | | | 6 | | | |
Net cash provided by (used for) investing activities | | | | (1,190) | | | |
Cash flows from financing activities | | | | | | | |
Proceeds from issuance of long-term debt, net of commissions | | | | 2,124 | | | |
Repayments of long-term debt | | | | (1,138) | | | |
Cash dividend of SFMC | | | | (10) | | | |
Withholding tax on share-based compensation | | | | 0 | | | |
Proceeds from intercompany note payable | | | | 0 | | | |
Payments on intercompany note payable | | | | 0 | | | |
Net cash provided by (used for) financing activities | | | | 976 | | | |
Net change in cash and cash equivalents and restricted cash and restricted cash equivalents | | | | 138 | | | |
Cash and cash equivalents and restricted cash and restricted cash equivalents at beginning of period | | | | 467 | | | |
Cash and cash equivalents and restricted cash and restricted cash equivalents at end of period | | 605 | | 605 | | | |
Supplemental cash flow information | | | | | | | |
Cash and cash equivalents | | | | | | 244 | 413 |
Restricted cash and restricted cash equivalents | | | | | | 169 | 192 |
Total cash and cash equivalents and restricted cash and restricted cash equivalents | | 605 | | 467 | | | 605 |
Supplemental non-cash activities | | | | | | | |
Transfer of finance receivables to real estate owned | | | | 5 | | | |
Net unsettled investment security purchases | | | | (2) | | | |
Non-cash dividend of SFMC | | | | (28) | | | |
Adjustments | | | | | | | |
Cash flows from operating activities | | | | | | | |
Net income | | 0 | | 0 | | | |
Reconciling adjustments: | | | | | | | |
Provision for finance receivable losses | | 0 | | 0 | | | |
Depreciation and amortization | | | | 0 | | | |
Deferred income tax benefit | | | | 0 | | | |
Net loss on repurchases and repayments of debt | | 0 | | 0 | | | |
Share-based compensation expense, net of forfeitures | | | | 0 | | | |
Other | | | | 0 | | | |
Cash flows due to changes in: | | | | | | | |
Other assets and other liabilities | | | | 0 | | | |
Insurance claims and policyholder liabilities | | | | 0 | | | |
Taxes receivable and payable | | | | 0 | | | |
Accrued interest and finance charges | | | | 0 | | | |
Other, net | | | | 0 | | | |
Net cash provided by operating activities | | | | 0 | | | |
Cash flows from investing activities | | | | | | | |
Net principal originations of finance receivables held for investment and held for sale | | | | 0 | | | |
Cash advances on intercompany notes receivables | | | | 1,129 | | | |
Proceeds from repayments of principal on intercompany notes receivables | | | | (381) | | | |
Available-for-sale securities purchased | | | | 0 | | | |
Available-for-sale securities called, sold, and matured | | | | 0 | | | |
Trading and other securities called, sold, and matured | | | | 0 | | | |
Other, net | | | | 0 | | | |
Net cash provided by (used for) investing activities | | | | 748 | | | |
Cash flows from financing activities | | | | | | | |
Proceeds from issuance of long-term debt, net of commissions | | | | 0 | | | |
Repayments of long-term debt | | | | 0 | | | |
Cash dividend of SFMC | | | | 0 | | | |
Withholding tax on share-based compensation | | | | 0 | | | |
Proceeds from intercompany note payable | | | | (1,129) | | | |
Payments on intercompany note payable | | | | 381 | | | |
Net cash provided by (used for) financing activities | | | | (748) | | | |
Net change in cash and cash equivalents and restricted cash and restricted cash equivalents | | | | 0 | | | |
Cash and cash equivalents and restricted cash and restricted cash equivalents at beginning of period | | | | 0 | | | |
Cash and cash equivalents and restricted cash and restricted cash equivalents at end of period | | 0 | | 0 | | | |
Supplemental cash flow information | | | | | | | |
Cash and cash equivalents | | | | | | 0 | 0 |
Restricted cash and restricted cash equivalents | | | | | | 0 | 0 |
Total cash and cash equivalents and restricted cash and restricted cash equivalents | | 0 | | 0 | | | 0 |
Supplemental non-cash activities | | | | | | | |
Transfer of finance receivables to real estate owned | | | | 0 | | | |
Net unsettled investment security purchases | | | | 0 | | | |
Non-cash dividend of SFMC | | | | 0 | | | |
Independence | | | | | | | |
Cash flows from operating activities | | | | | | | |
Net income | | 39 | | 39 | | | |
Reconciling adjustments: | | | | | | | |
Provision for finance receivable losses | | 142 | | 314 | | | |
Depreciation and amortization | | | | 97 | | | |
Deferred income tax benefit | | | | 39 | | | |
Net loss on repurchases and repayments of debt | | 0 | | 1 | | | |
Share-based compensation expense, net of forfeitures | | | | 3 | | | |
Other | | | | (2) | | | |
Cash flows due to changes in: | | | | | | | |
Other assets and other liabilities | | | | 47 | | | |
Insurance claims and policyholder liabilities | | | | (36) | | | |
Taxes receivable and payable | | | | (56) | | | |
Accrued interest and finance charges | | | | 22 | | | |
Other, net | | | | 1 | | | |
Net cash provided by operating activities | | | | 469 | | | |
Cash flows from investing activities | | | | | | | |
Net principal originations of finance receivables held for investment and held for sale | | | | (568) | | | |
Cash advances on intercompany notes receivables | | | | 0 | | | |
Proceeds from repayments of principal on intercompany notes receivables | | | | 0 | | | |
Available-for-sale securities purchased | | | | (169) | | | |
Available-for-sale securities called, sold, and matured | | | | 246 | | | |
Trading and other securities called, sold, and matured | | | | 5 | | | |
Other, net | | | | (2) | | | |
Net cash provided by (used for) investing activities | | | | (488) | | | |
Cash flows from financing activities | | | | | | | |
Proceeds from issuance of long-term debt, net of commissions | | | | 509 | | | |
Repayments of long-term debt | | | | (1,116) | | | |
Cash dividend of SFMC | | | | 0 | | | |
Withholding tax on share-based compensation | | | | (2) | | | |
Proceeds from intercompany note payable | | | | 1,129 | | | |
Payments on intercompany note payable | | | | (381) | | | |
Net cash provided by (used for) financing activities | | | | 139 | | | |
Net change in cash and cash equivalents and restricted cash and restricted cash equivalents | | | | 120 | | | |
Cash and cash equivalents and restricted cash and restricted cash equivalents at beginning of period | | | | 654 | | | |
Cash and cash equivalents and restricted cash and restricted cash equivalents at end of period | | 774 | | 774 | | | |
Supplemental cash flow information | | | | | | | |
Cash and cash equivalents | | | | | | 714 | 421 |
Restricted cash and restricted cash equivalents | | | | | | $ 329 | 353 |
Total cash and cash equivalents and restricted cash and restricted cash equivalents | | $ 774 | | 654 | | | $ 774 |
Supplemental non-cash activities | | | | | | | |
Transfer of finance receivables to real estate owned | | | | 0 | | | |
Net unsettled investment security purchases | | | | (1) | | | |
Non-cash dividend of SFMC | | | | $ 0 | | | |